1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab treatment beyond investigator-assessed progression: Outcomes in patients with relapsed/refractory classical Hodgkin Lymphoma from the phase 2 CheckMate 205 study
    Meeting Abstract

    Cohen, J. B.; Engert, A.; Ansell, S. M.; Younes, A.; Trneny, M.; Savage, K. J.; Ramchandren, R.; Collins, G. P.; Fanale, M. A.; Armand, P.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Loss of Keap1 promotes KRAS-driven lung cancer and results in genotype-specific vulnerabilities
    Meeting Abstract

    Romero, R.; Sayin, V. I.; Shawn, D. M.; Bauer, M.; Singh, S. X.; LeBoeuf, S.; Karakousi, T. R.; Ellis, D. C.; Bhutkar, A.; Sanchez-Rivera, F.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Interrogating cancer drivers and dependencies using non-germline mouse models
    Meeting Abstract

    Lowe, S. W.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Rapid generation of carcinoma mouse models using in vivo electroporation
    Meeting Abstract

    Leibold, J.; Ruscetti, M.; Sanchez-Rivera, F. J.; Zamechek-Slais, L.; Lowe, S. W.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers
    Meeting Abstract

    Ruscetti, M.; Leibold, J.; Bott, M. J.; Shields, M.; Chen, C. C.; Fennell, M.; Chen, H. C.; Baslan, T.; Salgado, N. R.; Manchado, E.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Cancer modeling in the CRISPR age
    Meeting Abstract

    Ventura, A.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Treatment-free remission (TFR) in patients with chronic-phase chronic myeloid leukemia (CML-CP) with stable deep molecular response (DMR) discontinuing dasatinib (DASFREE)
    Meeting Abstract

    Shah, N. P.; Garcia-Gutierrez, J. V.; Jimenez-Velasco, A.; Larson, S.; Saussele, S.; Rea, D.; Mahon, F. X.; Levy, M. Y.; Gomez-Casares, M. T.; Pane, F.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Efficacy and safety of first-line bosutinib versus imatinib in the BFORE trial: 18-month follow-up
    Meeting Abstract

    Clark, R. E.; Gambacorti-Passerini, C.; Deininger, M.; Mauro, M. J.; Chuah, C.; Kim, D. W.; Dyagil, I.; Glushko, N.; Milojkovic, D.; Le Coutre, P.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukaemia applicable to patients treated with novel therapies and standard of care
    Meeting Abstract

    Hillmen, P.; Soumerai, J.; Zelenetz, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J.; Chanan-Khan, A.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save
  • Venetoclax (VEN) in patients with relapsed/refractory non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Davids, M.; Roberts, A.; Seymour, J.; Wierda, W.; Puvvada, S.; Gressick, L.; Alter, D.; Zhou, L.; Kim, S.; Verdugo, M.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save